Brostallicin and Cisplatin in Treating Patients With Metastatic Breast Cancer

NCT01091454 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

48

Enrollment

OTHER

Sponsor class

Conditions

Triple-negative Breast Cancer

Interventions

DRUG: brostallicin
DRUG: cisplatin

Sponsor

Alliance for Clinical Trials in Oncology

Collaborators

[object Object]